With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.
The Scientist
Most Recent
Ascribing benefits to the experience of devastating illness or trauma is fraught with hidden dangers.
Contributors
August 1, 2011
Meet some of the people featured in the August 2011 issue of The Scientist.
To ensure high-quality clinical trials of a malaria vaccine, organizers in rural Africa must first upgrade electrical and research infrastructures.
Gut bacteria may be the missing piece that explains the connection between diet and cancer risk.
A transcription factor can make adult stem cells behave like fetal stem cells.
An antibody that binds 16 different flu viruses offers hope for the long-sought universal vaccine.
As seven of the world’s top selling drugs expire over the next year, prescription prices are set to drop while generics fill in.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
